2023 Q4 Form 10-Q Financial Statement

#000143774923031976 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $5.544M $2.706M
YoY Change 22.49% -57.9%
Cost Of Revenue $3.579M $1.609M
YoY Change -5.22% -56.17%
Gross Profit $1.965M $1.097M
YoY Change 162.0% -60.2%
Gross Profit Margin 35.44% 40.54%
Selling, General & Admin $1.829M $1.798M
YoY Change -23.12% -33.43%
% of Gross Profit 93.08% 163.9%
Research & Development $37.00K $41.00K
YoY Change -7.5% 355.56%
% of Gross Profit 1.88% 3.74%
Depreciation & Amortization $37.00K $37.00K
YoY Change -28.85% -32.73%
% of Gross Profit 1.88% 3.37%
Operating Expenses $1.866M $3.448M
YoY Change -22.86% -45.96%
Operating Profit $99.00K -$742.0K
YoY Change -105.93% -1713.04%
Interest Expense -$127.0K $121.0K
YoY Change -66.93% 1628.57%
% of Operating Profit -128.28%
Other Income/Expense, Net $0.00 $34.00K
YoY Change -85.83%
Pretax Income -$27.00K -$708.0K
YoY Change -98.68% -347.55%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.00K -$708.0K
YoY Change -98.58% -393.78%
Net Earnings / Revenue -0.49% -26.16%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 224.5M 224.6M
Diluted Shares Outstanding 216.7M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $367.0K $739.0K
YoY Change 42.8% 58.58%
Cash & Equivalents $367.0K $739.0K
Short-Term Investments
Other Short-Term Assets $604.0K $793.0K
YoY Change -22.56% -16.53%
Inventory $3.826M $3.783M
Prepaid Expenses
Receivables $289.0K $489.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.086M $5.804M
YoY Change -13.06% -28.35%
LONG-TERM ASSETS
Property, Plant & Equipment $581.0K $194.0K
YoY Change 86.82% -44.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $101.0K $101.0K
YoY Change 0.0% 14.77%
Total Long-Term Assets $682.0K $817.0K
YoY Change -43.68% -38.39%
TOTAL ASSETS
Total Short-Term Assets $5.086M $5.804M
Total Long-Term Assets $682.0K $817.0K
Total Assets $5.768M $6.621M
YoY Change -18.31% -30.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.472M $1.293M
YoY Change 20.46% -14.14%
Accrued Expenses $1.215M $1.321M
YoY Change -9.8% -19.25%
Deferred Revenue $58.00K $142.0K
YoY Change -60.81% -42.04%
Short-Term Debt $700.0K $1.500M
YoY Change 133.33% 403.36%
Long-Term Debt Due $716.0K $200.0K
YoY Change -28.4% -80.0%
Total Short-Term Liabilities $4.754M $5.682M
YoY Change -0.61% 7.21%
LONG-TERM LIABILITIES
Long-Term Debt $1.048M $1.072M
YoY Change 598.67% 614.67%
Other Long-Term Liabilities $73.00K $115.0K
YoY Change -82.94% -78.14%
Total Long-Term Liabilities $1.121M $1.187M
YoY Change 93.94% 75.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.754M $5.682M
Total Long-Term Liabilities $1.121M $1.187M
Total Liabilities $5.875M $6.869M
YoY Change 9.59% 15.6%
SHAREHOLDERS EQUITY
Retained Earnings -$8.540M -$8.513M
YoY Change 32.46% 87.35%
Common Stock $229.0K $225.0K
YoY Change 4.57% 3.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$107.0K -$248.0K
YoY Change
Total Liabilities & Shareholders Equity $5.768M $6.621M
YoY Change -18.31% -30.09%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$27.00K -$708.0K
YoY Change -98.58% -393.78%
Depreciation, Depletion And Amortization $37.00K $37.00K
YoY Change -28.85% -32.73%
Cash From Operating Activities -$47.00K -$860.0K
YoY Change -76.26% 249.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -325.0K 1.256M
YoY Change 318.67%
NET CHANGE
Cash From Operating Activities -47.00K -860.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -325.0K 1.256M
Net Change In Cash -372.0K 396.0K
YoY Change 77.99% -1900.0%
FREE CASH FLOW
Cash From Operating Activities -$47.00K -$860.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$47.00K -$860.0K
YoY Change -77.51% 405.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-2066000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
219163631
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
219163631
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21898000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
6627000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2125000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
132000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
764000 usd
us-gaap Operating Expenses
OperatingExpenses
13007000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-136000 usd
us-gaap Interest Expense
InterestExpense
99000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
598000 usd
us-gaap Other Income
OtherIncome
-7000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3131000 usd
CY2023Q3 chuc Non Rule10b51 Arrangement Adopted Flag
NonRule10b51ArrangementAdoptedFlag
False
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001134765
CY2023Q3 chuc Non Rule10b51 Arrangement Terminated Flag
NonRule10b51ArrangementTerminatedFlag
False
CY2023Q3 chuc Rule10b51 Arrangement Terminated Flag
Rule10b51ArrangementTerminatedFlag
False
CY2023Q3 chuc Rule10b51 Arrangement Adopted Flag
Rule10b51ArrangementAdoptedFlag
False
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
12663000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5360000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6482000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
888000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
7000 usd
us-gaap Interest Expense
InterestExpense
363000 usd
CY2023Q3 us-gaap Other Income
OtherIncome
0 usd
CY2022Q3 us-gaap Other Income
OtherIncome
1000 usd
us-gaap Other Income
OtherIncome
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
240000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
235000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
492000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-708000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
286000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2066000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
356000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-708000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
241000 usd
us-gaap Net Income Loss
NetIncomeLoss
311000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216715553
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212823575
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215569818
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211967458
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216715553
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244091744
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215569818
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243235628
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-708000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3257000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
241000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3529000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1700000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
125000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2066000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-248000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
87000 usd
us-gaap Net Income Loss
NetIncomeLoss
311000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3529000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2066000 usd
us-gaap Net Income Loss
NetIncomeLoss
311000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
120000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
219000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
117000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
244000 usd
us-gaap Accretion Expense
AccretionExpense
139000 usd
us-gaap Accretion Expense
AccretionExpense
1000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-13000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
563000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
598000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
277000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
309000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
118000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
87000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
173000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
275000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-552000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
451000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
131000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
124000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
105000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
20000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1030000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1100000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-275000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-315000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-736000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1522000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
178000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-178000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
831000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 usd
chuc Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
1200000 usd
chuc Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
300000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1218000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
482000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-400000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
257000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
866000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
739000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
466000 usd
us-gaap Interest Paid Net
InterestPaidNet
97000 usd
us-gaap Interest Paid Net
InterestPaidNet
90000 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-169000 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-3000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1000 usd
chuc Minimum Accrued Interest Recognized
MinimumAccruedInterestRecognized
0 usd
chuc Minimum Accrued Interest Recognized
MinimumAccruedInterestRecognized
90000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Income Loss
OperatingIncomeLoss
-2301000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2066000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-736000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-248000 usd
CY2023Q3 chuc Working Capital
WorkingCapital
122000 usd
CY2022Q4 chuc Working Capital
WorkingCapital
1067000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
629000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
563000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
66000 usd
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 usd
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
us-gaap Depreciation And Amortization
DepreciationAndAmortization
117000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
244000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
842000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
725000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1293000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1222000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
609000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
631000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
129000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
137000 usd
CY2023Q3 chuc Customer Deposit Current
CustomerDepositCurrent
1031000 usd
CY2022Q4 chuc Customer Deposit Current
CustomerDepositCurrent
119000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
224000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3363000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2333000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1700000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
948000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q3 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
150000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2798000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-26000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
2772000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-708000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
241000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2066000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
311000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
246000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
598000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-708000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2066000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-287000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216715553
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212823575
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215569818
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211967458
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
31268169
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
31268170
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
216715553
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244091744
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215569818
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
243235628
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75036000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46381000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6003000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
231000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.45
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5772000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5768000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.56
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
526000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
522000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
113000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
127000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
338000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
382000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
113000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
127000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
338000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
382000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
118000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
130000 usd
us-gaap Lease Cost
LeaseCost
353000 usd
us-gaap Lease Cost
LeaseCost
385000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
202000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
387000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
440000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M2D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
90000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
385000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
75000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
549000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
526000 usd

Files In Submission

Name View Source Status
0001437749-23-031976-index-headers.html Edgar Link pending
0001437749-23-031976-index.html Edgar Link pending
0001437749-23-031976.txt Edgar Link pending
0001437749-23-031976-xbrl.zip Edgar Link pending
chuc-20230930.xsd Edgar Link pending
chuc20230930_10q.htm Edgar Link pending
ex_586587.htm Edgar Link pending
ex_586588.htm Edgar Link pending
ex_586589.htm Edgar Link pending
ex_586590.htm Edgar Link pending
ex_596926.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
image02.jpg Edgar Link pending
image03.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
chuc-20230930_lab.xml Edgar Link unprocessable
chuc-20230930_def.xml Edgar Link unprocessable
chuc-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chuc20230930_10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chuc-20230930_cal.xml Edgar Link unprocessable